TNGNQ

Tengion, Inc. TNGNQ

TNGNQ
Tengion, Inc. KLDO
Kaleido Biosciences, Inc. BXRXQ
Baudax Bio, Inc. IVBT
Innovation1 Biotech Inc. XENO
Xeno Transplants Corporation CALA
Calithera Biosciences, Inc. CMRA
Comera Life Sciences Holdings, Inc. NMRD
Nemaura Medical Inc. SYVC
Synovics Pharmaceuticals, Inc. SNNAQ
Sienna Biopharmaceuticals, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode TNGNQ KLDO BXRXQ IVBT XENO CALA CMRA NMRD SYVC SNNAQ
6M 900.00 % 0.00 % 0.00 % 0.00 % 0.00 % 400.00 % -50.00 % 0.00 % 0.00 % 0.00 %
YTD 900.00 % 0.00 % 900.00 % -80.00 % 0.00 % 66.67 % -50.00 % 0.00 % 0.00 % 0.00 %
1Y 900.00 % 0.00 % 900.00 % -80.00 % 0.00 % 400.00 % -50.00 % -50.00 % 0.00 % 0.00 %
3Y 9 900.00 % -90.91 % -99.96 % -99.79 % -50.00 % -99.98 % -99.99 % -99.99 % 0.00 % 0.00 %
5Y 9 900.00 % -100.00 % -99.96 % -98.33 % -93.59 % -100.00 % -100.00 % -100.00 % 0.00 % -98.61 %
10Y 9 900.00 % -100.00 % -99.96 % -99.98 % -97.14 % -100.00 % -100.00 % -100.00 % 0.00 % -100.00 %
From the beginning 9 900.00 % -100.00 % -99.96 % -99.98 % -99.90 % -100.00 % -100.00 % -100.00 % 0.00 % -100.00 %

Dividend